Healthcare - Biotechnology - NASDAQ - US
$ 4.835
-0.103 %
$ 609 M
Market Cap
-3.81
P/E
BALANCE SHEET
128 M
ASSETS
115 M
LIABILITIES
13.5 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Humacyte, Inc.
| Current Assets | 83.3 M |
| Cash & Short-Term Investments | 80.4 M |
| Receivables | 0 |
| Other Current Assets | 2.83 M |
| Non-Current Assets | 44.9 M |
| Long-Term Investments | 0 |
| PP&E | 44.9 M |
| Other Non-Current Assets | 0 |
| Current Liabilities | 18.4 M |
| Accounts Payable | 6.49 M |
| Short-Term Debt | 5.23 M |
| Other Current Liabilities | 6.73 M |
| Non-Current Liabilities | 96.2 M |
| Long-Term Debt | 54.9 M |
| Other Non-Current Liabilities | 41.3 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 80.4 | 149.8 | 217.5 | 39.9 | 93.7 |
| Short Term Investments | 0 | 2.1 | 8.0 | 0 | 0 |
| Receivables | 0 | 31 K | 0.2 | 0.1 | 0.6 |
| Inventory | 0 | 31 K | 1 | 1 | 1 |
| Other Current Assets | 2.8 | 4.6 | 3.7 | 1.4 | 0.6 |
| Total Current Assets | 83.3 | 154.2 | 229.3 | 41.4 | 95.0 |
| PP&E | 44.9 | 50.1 | 57.2 | 65.2 | 73.7 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | (50.1) | (57.2) | (65.2) | (73.7) |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 128.2 | 204.3 | 286.5 | 106.7 | 168.7 |
| LIABILITIES | |||||
| Accounts Payable | 6.5 | 1.6 | 2.1 | 2.3 | 3.3 |
| Short Term Debt | 5.2 | 10.9 | 2.0 | 4.2 | 1.6 |
| Other Current Liabilities | 6.7 | 7.1 | 6.8 | 4.6 | 6.0 |
| Total Current Liabilities | 18.4 | 19.6 | 11.1 | 11.2 | 10.8 |
| Long Term Debt | 54.9 | 39.2 | 49.2 | 24.6 | 25.6 |
| Deferred Tax Income | 0 | 0 | 0 | 0.1 | 0 |
| Other Liabilities | 41.3 | 28.6 | 104.2 | 421.0 | 0 |
| Total Liabilities | 114.7 | 87.4 | 164.4 | 457.0 | 36.5 |
| EQUITY | |||||
| Common Stock | 10 K | 543.5 | 536.7 | 1 K | 21 K |
| Retained Earnings | (537.3) | (426.5) | (414.6) | (388.1) | (321.6) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (822.8) | (421.0) | 0 |
| Total Equity | 13.5 | 116.9 | 122.2 | (350.3) | 132.2 |
| Total Liabilities and Equity | 128.2 | 204.3 | 286.5 | 106.7 | 168.7 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 103.4 | 103.1 | 40.0 | 12.4 | 20.1 |